Table 1.
Trans-activation | DNA-binding | Tumor | Karyotype |
---|---|---|---|
EAD | FLI-1 | Ewing's sarcoma family of tumours | t(11;22)(q24;q12) |
EAD | ERG | Ewing's sarcoma family of tumours | t(21;22)(q22;q12) |
EAD | ETV1 | Ewing's sarcoma family of tumours | t(7;22)(p22;q12) |
EAD | ETV4/E1AF | Ewing's sarcoma family of tumours | t(17;22)(q12;q12) |
EAD | FEV | Ewing's sarcoma family of tumours | t(2;22)(q33;q12) |
EAD (TLS) | CHOP | Myxoid liposarcoma | t(12;22)(q13;q12) |
EAD | ATF-1 | Malignant melanoma of soft parts/soft tissue clear cell sarcoma | t(12;22)(q13;q12) |
EAD | WT1 | Desmoplastic small round cell tumour | t(11;22)(p13;q12) |
EAD | ZSG | Small round cell sarcoma Ewing's sarcoma/PNET (rare) |
t(1;22)(p36.1;q12) |
EAD | POU5F1 (OCT3/4) | Undifferentiated bone sarcoma | t(6;22)(p21;q12) |
EAD | NR4A3 (CHN/TEC or NOR1) | Extraskeletal myxoid chondrosarcoma | t(9;22)(q22;q12) |
EAD | CIZ/NMP4 ZNF384 |
Acute leukaemia | t(12;22)(p13;q12) |
FUS (TLS) | CHOP | myxoid liposarcoma and round cell liposarcoma | t(12;16)(q13;p11) |
EWSR1 | ATF1/CREB1 | Angiomatoid fibrous histiocytoma | t(2;22)(q33;q12) |
EWSR1 | ERG | The Ewing sarcoma (ES) family of tumors | t(1;21;7)(q25;q22.3;q22) |
EWSR1 | CREB1 | Angiomatoid fibrous histiocytoma clear cell sarcoma |
t(2;22)(q34;q12) |
RBP56/hTAFII6 | CHN orphan nuclear receptor | Extraskeletal myxoid chondrosarcomas | t(9;17)(q22;q11.2) |
EWSR1 | hSNF5/INI1 (SMARCB1) | Extrarenal rhabdoid tumors of soft tissue/cell soft tissue sarcomas | t(1;11)(q12;q25) |
EWSR1 or Not identified | Not identified or Fli-1 |
EWS/PNET Soft tissue sarcoma |
t(18;19)(q23;q13.2) |
EWS | UQCRH | small round cell sarcoma | t(1;22)(p34;q12) |
EWSR1 | NFATC2 | (ES/PNET) | t(20;22)(q13;q12) |